Related Experiment Videos
Mutations in FL5.12 cells conferring resistance to apoptosis induced by interleukin-3 deprivation
1Novartis Pharma AG, Oncology, Molecular Genetics, CH-4002 Basel, Switzerland.
Abstract:
In an attempt to dissect the signal pathway in which Bax increases cellular responses to apoptotic stimuli and leads to the activation of the caspase cascade, we mutated FL5.12 Bax CL16 cells with a chemical mutagen. In this report we characterize two mutant clones, FL5.12 ms1 and m3. Both clones are resistant to IL-3 deprivation exhibiting no changes in mitochondrial membrane potential, annexin V and propidium iodide binding. FL5.12 ms1 is also resistant to staurosporine and anti-Fas antibody. In cell fusion experiments m3 behaves genetically dominant and ms1 is recessive. The results suggest that m3 has a mutation in a specific function upstream of Bax, while ms1 has a mutational block in the general pathway downstream of the 'Bcl-2 checkpoint'.
Insights
Researchers investigated the cell death pathway by creating mutated cells. They identified two mutants resistant to apoptosis, suggesting distinct genetic blocks in the cell death signaling cascade.
Area of Science:
- Cell Biology
- Molecular Biology
- Apoptosis Research
Background:
- Bax protein is crucial for initiating apoptosis, a programmed cell death process.
- Understanding the Bax signaling pathway is key to controlling cellular responses to death stimuli.
- The caspase cascade is a central executioner pathway in apoptosis.
Purpose of the Study:
- To identify genetic mutations affecting the Bax-mediated apoptotic pathway.
- To dissect the specific roles of upstream and downstream components in apoptosis signaling.
- To characterize novel cellular responses to apoptotic stimuli.
Main Methods:
- Chemical mutagenesis of FL5.12 Bax CL16 cells.
- Selection and characterization of apoptosis-resistant mutant clones (ms1 and m3).
- Assays for mitochondrial membrane potential, annexin V, and propidium iodide binding.
- Genetic analysis using cell fusion experiments.
Main Results:
- Two Bax-resistant mutant clones, ms1 and m3, were isolated.
- Both clones showed resistance to interleukin-3 (IL-3) deprivation without altered mitochondrial integrity or key apoptosis markers.
- Clone ms1 exhibited resistance to staurosporine and anti-Fas antibody, while m3 showed dominant genetic behavior.
- Genetic analysis indicated m3 has an upstream mutation, and ms1 has a downstream mutation relative to the Bcl-2 checkpoint.
Conclusions:
- Mutations in ms1 and m3 provide insights into the Bax signaling pathway.
- Clone m3 likely harbors a defect in a component upstream of Bax.
- Clone ms1 appears to have a defect downstream of the Bcl-2 regulated checkpoint in the apoptotic cascade.